Bernard Birkett
Interim Chief Executive OfficerBernard Birkett, current Avalign Chief Financial Officer, has been named Interim Chief Executive Officer. Bernard joined Avalign in January and brings significant operational and financial leadership experience to this interim role.
Mr. Birkett was named Chief Financial Officer for Avalign Technologies in January 2026 and Interim CEO in October 2026.
Bernard brings more than two decades of global financial leadership experience in the medical device and manufacturing industries. He most recently served as Senior Vice President and Chief Financial Officer at West Pharmaceutical Services, Inc, and previously held the role of CFO and Treasurer at Merit Medical Systems. His career has spanned Europe, the Middle East, and the United States, where he has been recognized for his operational acumen, strategic vision, and ability to drive sustainable top-line and bottom-line growth.
Bernard earned his degree in Business from the National University of Ireland in Galway; a Master’s in Banking and Finance from Smurfit Business School in Dublin and completed the Strategic Leadership Program for CFOs at Stanford Graduate School of Business.
